Live feed07:30:00·35dPRReleasevia QuantisnowImmunityBio Confirms Statistical Power in Pivotal Randomized BCG-Naïve NMIBC Trial to Detect Clinically Meaningful Differences Between ANKTIVA® Plus BCG Versus BCG Alone; Supplemental BLA Submission on Track for 2026ByQuantisnow·Wall Street's wire, on your screen.IBRX· ImmunityBio Inc.Health Care
